Search - tctmd.com

Displaying 261 - 280 of 337

Sort: Relevancy | Date

News Conference News AHA 2017

Novel Interatrial Shunt Succeeds in HF Hemodynamic Study: REDUCE LAP-HF I

Michael O'Riordan

November 21, 2017

Presentation TCT 2017

First Report of the Six Month Outcomes of the MAVERIC Trial of Transcatheter Annular Reduction Therapy (TART) With the ARTO System for Functional Mitral Regurgitation (FMR)

Presenter: Daniel Burkhoff, Samir R. Kapadia, Stephen G. Worthley

November 01, 2017

Presentation TCT 2017

Editorial Perspective: Device-based Neuromodulation and Interventional HF Therapy

Presenter: Louis A. Cannon, Peter J. Fitzgerald, Juan F. Granada, Emerson C. Perin

October 31, 2017

News Conference News TCT 2017

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Shelley Wood

October 20, 2017

News Daily News

FDA Grants HeartWare LVAD a Destination Therapy Indication

Todd Neale

September 28, 2017

News Industry News

Boston Scientific Announces U.S. FDA Approval for MRI Labeling on High-Voltage Devices and U.S. Launch of Resonate™ Devices with the HeartLogic™ Heart Failure Diagnostic

September 25, 2017

News Industry News

Boston Scientific Announces Positive Late-Breaking Clinical Trial Data for the HeartLogic™ Heart Failure Diagnostic

September 19, 2017

News Opinion Editor's Corner ESC 2017

My Takeaways From ESC 2017: That Lovin’ Feeling? Barcelona Brings It Back

Shelley Wood

September 08, 2017

News Opinion Editor's Corner ESC 2017

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On

Shelley Wood

August 18, 2017

Manuscript

Device-based Therapy for Mitral Regurgitation and Ventricular Reshaping

August 11, 2017

Presentation CHIP Seattle 2017

Ischemic Cardiomyopathy: Medical Therapy and Devices

Presenter: Ryan C. Martin

August 10, 2017

News Industry News

Fewer Leads, Fewer Complications: BIOTRONIK US Launches Proven DX Technology for Heart Failure Patients

July 20, 2017

News Daily News

Palliative Care Ups Quality of Life, Mental Health for HF Patients

Caitlin E. Cox

July 19, 2017

News Conference News TVT 2017

Mitral Valve Repair Technologies Inch Forward, but Question of Combination Therapy Looms

Shelley Wood

June 15, 2017

News Conference News TVT 2017

Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10

Shelley Wood

June 12, 2017

News Industry News

Medtronic First to Receive FDA Approval for MR-Conditional Quadripolar Cardiac Resynchronization Therapy-Pacemakers

May 11, 2017

News Daily News

HF Survival Rates Worse Than Those of Common Cancers, Including Bladder and Breast Cancer

Michael O'Riordan

May 10, 2017

News Daily News

Updated PARTNER 2 Valve-in-Valve Registry: More Experience, Better Outcomes

Shelley Wood

May 02, 2017

News Conference News

Mixed Results, With Some Promising Data, in Heart Failure Destination Therapy Trial

Todd Neale

April 07, 2017

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Shelley Wood

March 10, 2017

Advertisement

Novel Interatrial Shunt Succeeds in HF Hemodynamic Study: REDUCE LAP-HF I

First Report of the Six Month Outcomes of the MAVERIC Trial of Transcatheter Annular Reduction Therapy (TART) With the ARTO System for Functional Mitral Regurgitation (FMR)

Editorial Perspective: Device-based Neuromodulation and Interventional HF Therapy

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

FDA Grants HeartWare LVAD a Destination Therapy Indication

Boston Scientific Announces U.S. FDA Approval for MRI Labeling on High-Voltage Devices and U.S. Launch of Resonate™ Devices with the HeartLogic™ Heart Failure Diagnostic

Boston Scientific Announces Positive Late-Breaking Clinical Trial Data for the HeartLogic™ Heart Failure Diagnostic

My Takeaways From ESC 2017: That Lovin’ Feeling? Barcelona Brings It Back

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On

Device-based Therapy for Mitral Regurgitation and Ventricular Reshaping

Ischemic Cardiomyopathy: Medical Therapy and Devices

Fewer Leads, Fewer Complications: BIOTRONIK US Launches Proven DX Technology for Heart Failure Patients

Palliative Care Ups Quality of Life, Mental Health for HF Patients

Mitral Valve Repair Technologies Inch Forward, but Question of Combination Therapy Looms

Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10

Medtronic First to Receive FDA Approval for MR-Conditional Quadripolar Cardiac Resynchronization Therapy-Pacemakers

HF Survival Rates Worse Than Those of Common Cancers, Including Bladder and Breast Cancer

Updated PARTNER 2 Valve-in-Valve Registry: More Experience, Better Outcomes

Mixed Results, With Some Promising Data, in Heart Failure Destination Therapy Trial

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content